Who owns the GLYPH2BLSD trademark?

The GLYPH2BLSD trademark is owned by Seaport Therapeutics, Inc..

What is the serial number for GLYPH2BLSD?

The USPTO serial number for GLYPH2BLSD is 99336889.

What is the registration number for GLYPH2BLSD?

GLYPH2BLSD is registered under USPTO registration number 0.

GLY

USPTO Trademark Record

PENDING

GLYPH2BLSD

Q: What class is the GLYPH2BLSD trademark registered in?

The GLYPH2BLSD trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

SN 99336889·Reg 0·Filed Aug 14, 2025

Owner Seaport Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

GLYPH2BLSD (Serial No. 99336889), Registration No. 0, is a pending US trademark filed on Aug 14, 2025 by Seaport Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: March 24, 2027168 days remaining

Mark Intelligence

GLYPH2BLSD (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 14, 2025

SERIAL

99336889

REG#

Owner

Applicant

Seaport Therapeutics, Inc.

Entity

Corporation

State

Address

101 Seaport Blvd., Floor 12, Boston, MA, 02210

Country

Attorney

NameNicholas B. Hawkins

Law firm

Nicholas B. Hawkins Womble Bond Dickinson (US) LLP

Docket

122621.0001.7

Address

888 Seventh Avenue, 38th Floor, New York, NY 10106, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateAug 14, 2025

Serial Number99336889

Registration No.0

Status DateSep 22, 2026

Published for OppositionJan 27, 2026

Mark TypeStandard characters

Attorney Docket122621.0001.7

Status DescriptionLive and pending, first extension granted

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 23, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 22, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 22, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 22, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 24, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 27, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 27, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 21, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 02, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Dec 30, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 29, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 14, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 14, 2025

APPLICATION FILING RECEIPT MAILED

GLYPH2BLSD

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Seaport Therapeutics, Inc.

Other Marks by Nicholas B. Hawkins

Resources

Company